Makers Laboratories Ltd.

View in App
109.50 +2.20 ▲2.1%

06 June 2023, 04:01:00 PM
Volume: 1,168

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.makerslabs.com
Market Cap 64.31 Cr.
Enterprise Value(EV) 71.70 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -8.05 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 33.76 Trailing Twelve Months Ending 2023-03
Book Value / Share 117.28 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.93 Calculated using Price: 109.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.59 Cr. 5,900,376 Shares
FaceValue 10
About Makers Laboratories Ltd.
Makers Laboratories was incorporated in 1985. The company is promoted and managed by Ipca Laboratories group. The company is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The company's plants are located in Palghar and Dombivli in Thane (Maharashtra). The company has a prominent presence in the therapeutic segment of antibiotics.

Makers Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Makers Laboratories Ltd. Performance

View details >>
1 Day
+2.05%
1 Week
-0.45%
1 Month
+1.58%
3 Month
-4.74%
6 Month
-16.00%
1 Year
-28.36%
2 Year
-51.95%
5 Year
+60.30%
10 Year
+470.61%

Makers Laboratories Ltd. Fundamental Ratios

View details >>
2 years 2021-03 2022-03
Return on Equity (%) 2.49 20.61
Return on Capital Employed (%) 6.53 24.00
Return on Assets (%) 0.99 8.35

Makers Laboratories Ltd. Balance Sheet

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 54 60 69
Non Curr. Liab. 17 13 15
Curr. Liab. 33 33 28
Minority Int. 32 39 40
Equity & Liab. 136 144 152
Non Curr. Assets 75 81 89
Curr. Assets 61 63 63
Misc. Exp. not W/O
Total Assets 136 144 152

Makers Laboratories Ltd. Profit and Loss

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 69 127 101
Other Income 1 3 2
Total Income 70 130 104
Total Expenditure -61 -108 -98
PBIDT 9 21 6
Interest -2 -2 -2
Depreciation -5 -4 -4
Taxation -1 -4 -1
Exceptional Items 0
PAT 1 12 -2
Minority Interest -2 -7 -3
Share Associate
Other Related Items
Consolidated Net Profit 0 5 -5
Adjusted EPS -1 10 -8

Makers Laboratories Ltd. Cash Flow

View details >>
Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 9
Cash Fr. Inv. -12
Cash Fr. Finan. 0
Net Change -3
Cash & Cash Eqvt 2

Makers Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 58.37 58.37 58.37 58.37 58.37 61.27 61.27 61.27 61.27
Public 41.63 41.63 41.63 41.63 41.63 38.73 38.73 38.73 38.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Makers Laboratories Ltd. Announcements

View details >>
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
We are enclosing herewith a certified copy of the Annual Secretarial Compliance Report for the period ended 31st March 2023 under Regulation 24A issued by M/s. Parikh & Associates practicing Company Secretaries.
Wed, 24 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of the Audited Financial Results for the 4th quarter and financial year ended 31st March 2023 published on 23rd May 2023 in Financial Express (all India editions) Nav Shakti (in Marathi) and Free Press Journal.
Mon, 22 May 2023
Standalone And Consolidated Audited Results For FY23
Standalone and Consolidated Audited Results for FY23

Makers Laboratories Ltd. Technical Scans

View details >>
Tue, 06 Jun 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
High Decrease in 2 Years High Decrease in 2 Years
Closing Near 50 SMA Closing Near 50 SMA

Makers Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,184.60 1,013.55 +0.4%
Divi's Laboratories Ltd. 93,886.95 3,536.65 +2.2%
Cipla Ltd. 78,522.76 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. 77,195.89 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. 71,115.89 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. 60,794.95 1,796.30 +1.2%
Mankind Pharma Ltd. 59,699.70 1,490.30 +4.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.70 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 51.49 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 28.02 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.13 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.83 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.83 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 44.71 1,490.30 +4.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.34 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.35 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 3.35 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.32 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.49 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.81 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 5.75 1,490.30 +4.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 0.04 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,490.30 +4.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,490.30 +4.6%

Makers Laboratories Ltd. FAQ's

What is Makers Laboratories share price?
Can I buy Makers Laboratories shares now?
What is the Market Cap of Makers Laboratories?
What are the key metrics to analyse Makers Laboratories?
What is the 52 Week High and Low of Makers Laboratories?
What is the trend of Makers Laboratories share price?